GlassScriptPhysician profile
Douglas A Goderwis
NPI 1760439095
$11,490.38
in general payments reported to CMS, 2019-2025
51 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,816 · 2020: $534 · 2021: $1,277 · 2022: $1,743 · 2023: $2,067 · 2024: $2,196 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,119.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,560.87 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,123.80 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,012.60 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $913.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $744.09 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Sanofi-Aventis U.S. LLC | $644.72 | 2019-2025 | |
| Pfizer INC. | $611.11 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $444.35 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $347.23 | 2019-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $300.14 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $282.02 | 2021-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $277.74 | 2019-2025 | Qelbree, Qelbree |
| Novartis Pharmaceuticals Corporation | $269.55 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $259.39 | 2019-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $220.72 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $220.44 | 2021-2025 | Injectafer |
| Abbott Laboratories | $194.73 | 2021-2025 | Freestyle Libre 3 |
| Allergan, INC. | $186.46 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $182.24 | 2019-2022 | |
| Exact Sciences Corporation | $177.96 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $174.56 | 2023-2025 | Gemtesa |
| Amarin Pharma, INC. | $142.78 | 2019-2022 | |
| Axsome Therapeutics, INC. | $110.97 | 2023-2025 | Auvelity, Symbravo |
| Sunovion Pharmaceuticals INC. | $97.52 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $97.50 | 2021-2023 | Ajovy, Airduo Digihaler |
| Takeda Pharmaceuticals U.S.A., INC. | $96.18 | 2019-2022 | |
| Astellas Pharma US INC | $82.70 | 2023-2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $82.15 | 2022-2024 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $69.03 | 2025 | Caplyta |
| Almatica Pharma LLC | $52.60 | 2022-2023 | Gralise |
| Radius Health, INC. | $51.29 | 2019-2025 | Tymlos |
| Lundbeck LLC | $43.26 | 2025 | Rexulti |
| Beta Bionics, INC. | $39.54 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Kowa Pharmaceuticals America, INC. | $35.45 | 2022-2023 | Seglentis |
| Biohaven Pharmaceutical Holding Company LTD. | $34.72 | 2022 | |
| Boston Scientific Corporation | $31.73 | 2019 | |
| Dexcom, INC. | $29.65 | 2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $24.73 | 2022 | |
| Biogen, INC. | $22.73 | 2021 | |
| Optinose US, INC. | $19.94 | 2025 | |
| Dynavax Technologies Corporation | $19.74 | 2025 | Heplisav-B |
| Eisai INC. | $19.36 | 2021 | |
| Tolmar, INC. | $18.39 | 2025 | Jatenzo |
| Ironshore Pharmaceuticals INC. | $17.37 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.78 | 2023 | Linzess |
| Biohaven Pharmaceuticals, INC. | $16.52 | 2021 | |
| Esperion Therapeutics, INC. | $14.66 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.58 | 2025 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $13.79 | 2024 | Camzyos |
| Evoke Pharma, INC. | $13.43 | 2024 | |
| Zyla Life Sciences, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Goderwis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.